Quest Diagnostics Inc

DGXNYSE · USD
255.63USD+0.89 (+0.35%)
779

Quest Diagnostics Inc (DGX) Option Chain

Quest Diagnostics Inc trades at $255.63, up 0.35%, with an IV Rank of 86.11%. This is high versus the past year, and the company carries a market cap of $28,026M in the Diagnostics & Research industry. On the Nov 20, 2026 chain, the at the money $260.00 strike shows calls at $2.70 / $4.70 and puts at $7.80 / $10.40, both carrying about $4.21 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $260.00 calls, at 15 contracts, and the $240.00 puts, at 23, as of Nov 5, 2026.

Read more

Tracking the DGX option chain helps you see every strike and expiry on Quest Diagnostics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of DGX options activity at a glance. Use our scanner to monitor the DGX option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For DGX stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where DGX options are being actively traded, and where they are not.

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
16.6938600.4715.6314.5017.70240.00-5.790.253.600.001.932374083.31
38.1567853.275.638.309.50250.00-1.862.655.600.004.132055961.85
63.20472153.700.002.704.70260.00+2.067.8010.404.374.730036.80
82.9471912.230.000.953.50270.00+5.9915.4017.9014.372.280017.06
93.8712400.530.000.051.00280.00+9.9224.3027.2024.371.38006.13

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryDiagnostics & Research
  • SectorHealthcare
  • IV Rank86.11% High
  • Market cap (M$)28,026
  • 52 weeks high-0.88%
  • 52 weeks low48.81%
  • Analyst recommendationBuy
    2.06
  • Target price$258.29
    1.04% above the current stock price
  • Dividend—
  • Payout ratio36.60%
  • Earnings date2026-10-22
  • P/E25.36
  • Future P/E21.27
  • EPS (ttm)10.04
  • EPS growth next 5 years9.85%

As of Nov 5, 2026